A Trusted Global Leader in Purified Cannabis Concentrates
This website contains information about cannabis.
Please enter your birthday to confirm that you are of the legal age to consume cannabis in your province.
This website contains information about cannabis.
Please enter your birthday to confirm that you are of the legal age to consume cannabis in your province.
MediPharm Labs is built on the foundation of a strong executive team, with professionals from complementary industries that include global pharmaceuticals, healthcare, consumer packaged goods, and biotechnology manufacturing. Our company is a recognized leader in the Cannabis services industry, and our science-based team delivers quality and innovation through research, discipline, and forward thinking.
CEO & Chairman of the Board
Before founding MediPharm Labs, Pat enjoyed a 15-year career in the pharmaceutical industry in top sales roles at Sanofi Canada and AstraZeneca Canada, successfully launching a wide range of medical products. He most recently worked at Janssen Pharmaceuticals (Johnson & Johnson) where he led the Hospital Division for Renal and Mental Health products, helping to develop new strategic products and customized drug [bundling] programs for hospitals and specialty patient groups. Pat brought his pharmaceutical perspective to the cannabis industry, with a mission from the outset for MediPharm Labs to standout as a global leader in the pharma-quality manufacture of cannabinoid-based products.
Under Pat’s visionary leadership, MediPharm Labs emerged as a leading specialized contract manufacturing organization (CMO) for Canada’s newly legalized adult-use market, while simultaneously building a multi-jurisdictional, GMP-certified platform to supply the global medical cannabis market. His drive fuelled his chosen team to secure the coveted international pharma-standard GMP licences in short order while also launching a broad range of product formats and production capabilities for medicinal, wellness and adult-use brands.
Pat took MediPharm Labs public on the TSX Venture Exchange in October 2018, shortly thereafter, the OTCQX and FSE exchanges and up-listed to the TSX in July 2019. Pat is a frequent speaker at international cannabis events and conferences. He holds an Honours Bachelor of Science degree in biology from the University of Western Ontario.
President & Director
Keith Strachan co-founded MediPharm Labs in 2015, utilizing his consultancy expertise in Public Sector RFP and government contracts, compliance for government licensing and local planning, to break the mold and secure the first Health Canada Licence for cannabis oil production without first being a cultivator. A seasoned entrepreneur, Keith has applied his leadership to building out MediPharm Labs’ leading-edge facilities, launching operations and growing its workforce, while also strategically driving business development with the Company’s many supply, contract processing and white label partner LPs.
General Counsel and Head of Corporate Development
Ahmed comes to MediPharm after having spent over a decade working in the Bay Street offices of the Business Law Group of one of the world's largest law firms and in the Corporate Law Group of a global leader in Canadian business law. His legal practice consisted of securities law, mergers & acquisitions, corporate finance and general corporate and commercial law. Ahmed has acted as external counsel for numerous cannabis companies and has been involved in a legal advisory role in the going public transactions of cannabis companies as well as companies in several other industries. He holds a Juris Doctor Law Degree from Osgoode Hall Law School and a Bachelor of Commerce Honours Degree with First Class Honours from the Queen's University School of Business.
Executive Vice President, Global Accounts
A Molecular Biologist by training, Kirk Binns was a founding shareholder of MediPharm Labs. A serial entrepreneur, Kirk has spent most of his career in the North American deregulated energy markets, leading market expansions, client acquisitions and managed up to 100 reports across multiple markets. Over the last 12 years, he established and ran a multinational energy sales organization generating 7-figures annually, while also contributing to MediPharm Labs’ start-up and operations. Kirk takes on the role of EVP, Global Accounts to help MediPharm Labs realize its vision as the trusted global leader in cannabinoid-based derivatives.
Chief Executive Officer, Asia Pacific
Warren brings a wealth of senior leadership to MediPharm Labs Australia, having run both his own small businesses as well as achieved success in the Asia Pacific for a leading international digital marketing agency. Warren completed an Honours Bachelor Computer Science (programming) and was on the leading edge of web development and digital marketing, working first in Canada and the UK before building the Asia Pacific division of a large enterprise marketing agency, MarketOne. Over 8 years, Warren opened four offices, adding 200+ staff in Melbourne, Singapore, Bangalore and Tokyo. He boasts a 15-year history in sales and marketing, consulting to some of the biggest companies in the world.
Vice President, Finance
Over his 12-year career, Jason has provided financial expertise to various public entities in capital market strategies, M&A advisory, valuation, financial forecasting and financial due diligence. Most recently, Jason held senior finance positions at Aurora Cannabis Inc., playing a key role in their merger with MedReleaf Corp. He previously worked in the strategy and corporate development group at Methanex Corporation, held roles at FTI Consulting Inc., and MNP LLP, in transaction advisory capacities, and held positions in the audit and assurance practice at PricewaterhouseCoopers LLP, Canada. Mr. Nalewany is a Canadian Chartered Professional Accountant (CPA, CA) and holds a Bachelor of Commerce degree from the University of Victoria.
Vice President, Sales
Brett joins MediPharm Labs with over a decade of sales, marketing and CPG experience. Previously Brett was Vice President at Mosaic Sales Solutions – Canada’s largest sales and marketing agency. At Mosaic, Brett led accounts such as Anheuser Busch InBev, Nike, and Nestle. Recently Brett has led sales in the cannabis industry, working and consulting for some of the largest LPs in Canada. As VP of Sales at MediPharm Labs, Brett will be accountable for maximizing the sales and distribution of MediPharm’s best-in-class vape, and other innovative cannabis products.
Vice President, Investor Relations & Communications
Laura Lepore brings more than 16 years of award-winning Investor Relations, Communications and Capital Markets experience across Financial, Industrial and Mining sectors. Laura was most recently AVP, Investor Relations at Home Capital Group Inc. and led IR through two significant transactions and a governance renewal. During her tenure with TD Bank Financial Group she held various roles in IR and Corporate Banking. Previously Laura was Director of IR for Newmarket Gold and Crocodile Gold. She earned her Bachelor of Arts, Economics from York University and is currently a Board Director for the Canadian Investor Relations Institute, Ontario Chapter.
Vice President, Quality and Scientific Affairs
Chris has 24 years of experience in the bio-pharmaceutical field, having been involved in all aspects of development from bench-top to commercial manufacture. After completing his BSc. and Doctorate degrees in Biochemistry, he joined Hemosol as a research scientist and then transitioned into the Process Development group where he worked on scaling up the manufacturing process to support clinical manufacturing of a haemoglobin-based blood substitute. Thereafter, he managed the clinical manufacturing plant. An expert in Chromatography, Dr. Talpas comes to MediPharm with a wealth of expertise in the qualification and validation of complex processes and equipment, as well as the development and maintenance of quality systems, having just served as the Director of Manufacturing Sciences at Therapure Biopharma.
Head of Quality
A Certified Pharmaceutical GMP Professional (CPGP) with over 18 years of experience in the pharmaceutical and medical device industry, Nigel Dewsbury brings considerable expertise in quality systems and management to the MediPharm Labs team. Prior to joining MediPharm Labs, Nigel held senior quality assurance roles with a variety of organizations, including Baxter Healthcare, Derma Sciences Inc. and Nuvo Research Inc. He boasts a successful record of hosting regulatory authorities, including Health Canada and the U.S. Food and Drug Administration, as well as working with third-party auditors and ISO registrars. Nigel holds a Bachelor of Science degree in Chemistry from the University of Western Ontario and a Certified Six Sigma Green Belt designation from McGill University.
Vice President, Associate General Counsel
Geoff brings over a decade of legal experience at top Canadian brands and on Bay Street. Most recently he held a senior position at Canada Goose, where he was a strategic legal and business advisor for the company’s first retail store openings, e-commerce expansion, supply chain initiatives, and its launch into China and Hong Kong. He also supported the business through its IPO process on the TSX and NYSE. Geoff has a strong background in marketing and intellectual property law, and ran Canada Goose’s global IP and brand protection programs. Prior to Canada Goose, Geoff was in-house counsel for Tim Hortons, and a corporate lawyer in private practice, working in venture capital and M&A.
Manager of Research and Development
Dr. Tait Gale is a scientist with experience in natural product and infectious disease research. Before joining the team at MediPharm Labs, Dr. Gale was the Director of Research and Development at Green Relief where he led a team of staff-scientists focused on process optimization and product development. He was responsible for bringing industry-leading products to market using chromatography and honed his craft in minor cannabinoid isolation. Dr. Gale completed a PhD in Biochemistry from McMaster University, one of Canada's premier drug discovery laboratories, and is the author of many publications in the fields of biochemistry, chemistry, and microbiology, including work on the antibiotic potential of cannabis.
Director of Operations, Asia Pacific
Jake has nearly 20 years of experience in the bio-tech, medical device and pharmaceutical fields, in the development and commercialisation of a variety of products. After completing his BSc. and Doctorate degrees in Chemistry, he joined the Commonwealth Scientific and Industrial Research Organisation as a post-doctoral fellow. He then transitioned into private industry joining Southern Dental International in product development before moving to Boron Molecular taking up Operational and Quality Manager positions. With a wide range of experience in process and production chemistry, Dr. Golding comes to MediPharm Labs with a wealth of expertise in the registration, qualification and validation of processes, facilities and equipment, as well as the development and maintenance of quality systems. Jake most recently served as the Head of Quality at Medical Developments Australia.
Director of Global Regulatory and Scientific Affairs
Anuja has 8 years of experience in cannabis research, academia and work in the regulated cannabis industry in Canada. Most recently, Anuja worked as a Senior Quality/Regulatory Consultant at Cannabis Compliance Inc., global cannabis consulting firm. In that role, she provided quality and regulatory consulting services to over 50 clients, assisting with operational gap assessment and GPP/GMP audits, guiding close to one dozen clients with licence receipt from Health Canada, and navigating through the cannabis regulatory jurisdiction of multiple countries/US states. Previously Anuja worked for 2.5 years at Aphria Inc., one of Canada’s leading LPs in a senior role in the Quality Department. She has spoken at numerous scientific conferences and published in peer-reviewed scientific journals. Anuja holds a Master’s degree in Medical Sciences Program from McMaster University.
Director of Human Resources
Lorna has a 25-year career as a Human Resources executive working in both the UK and Canada, with a forward-thinking perspective. For the last nine years she headed up the Human Resources department at Steam Whistle Brewing, developing and implementing best practices to build high performing teams aligned to company objectives and values. Lorna is an approachable, collaborative leader with expertise in recruitment and on-boarding of new talent, and development of employees and managers through trusted mentoring and coaching. Lorna was part of the senior leadership team at Steam Whistle Brewing which won many awards, including 9-years recognition as one of Canada's Best Managed Companies. Lorna completed the Post Graduate Human Resource Management program from Ryerson University.
Senior Director, Project Management Office and Facilities
Saravan has worked in the Pharmaceutical Industry for over 12 years in roles focusing on Engineering and Technical Services. He has led projects which included new product launches in both Manufacturing and Commercial environments, and the design of a $30M High Containment Facility for the manufacturing of Soft Gel Capsules. Previously, he was a Project Manager in the Automotive Sector. Saravan is an authentic leader of successful teams by modelling a collaborative and hands on approach, providing opportunities for shared leadership, communicating effectively and motivating teams towards shared goals. Saravan obtained his bachelor’s degree in Electrical Engineering at the University of Waterloo, and recently completed his Executive MBA at the Rotman School of Management, University of Toronto.
Director of Facility Operations
Darren Parker brings over 20 years of experience in Health and Safety, Law Enforcement and Facility Operations Management to the MediPharm Labs team. Prior to entering the cannabis industry, Darren worked as a contracted Senior Health and Safety Inspector for Enbridge. In this role, he was responsible for conducting worksite inspections, audits, incident investigations, contractor management and evaluations, while ensuring that provincial and federal safety requirements were met. Darren’s expertise in Health and Safety came primarily from the Oil and Gas, Energy and Construction sectors, where he became versed in developing Safe Work Practices and Procedures, Emergency Response Plans, Job Hazard Assessments, and Project Execution Plans. He has worked closely with provincial Health and Safety organizations to successfully deliver programs across multiple locations in Canada. Early in Darren’s career he spent close to a decade with Ontario Parks and the Ministry of Natural Resources as a Senior Park Warden and Operations Technician, operating in Parks as large as 13,000+ Hectares.
Director of Information Technology
Bill Gordon brings over 26 years in information technology and governance to the MediPharm Labs team. He previously held positions in the public sector, working for Canadian municipal and provincial law enforcement organizations in various I&IT roles focused on computer forensics, technical investigations, data centres, public safety applications, and IT security. Bill is a founding Director at MediPharm Labs, responsible for the design and implementation of the company’s data and network security systems in Canada and Australia. He leads our team of highly competent IT professionals, supporting our GMP infrastructure, manufacturing and enterprise applications. An active member of his community, Bill is an elected Municipal Councillor for the Town of Midland for the 2018-2022 term.
Director of New Product Commercialization
With 17 years of experience in capital project management and a working knowledge of cGMP regulations, Scarlett Gonzalez brings a wealth of expertise to her role at MediPharm Labs. Prior to joining our team, Scarlett worked for Canada’s largest generic pharmaceutical company Apotex Inc. where she was responsible for overseeing the Engineering Services Department as the Associate Director of Capital Engineering. While at Apotex, she was awarded a Global Certificate of Achievement with outstanding performance in operational efficiency, cost management and future growth. Scarlett holds a Bachelor of Applied Science and Engineering degree in Chemical Engineering from the University of Toronto and is a Professional Engineer of Ontario (P. Eng.).
Director of Finance
Olga Utkutug is a financial expert with over 21 years of experience in International Financial Reporting Standards (IFRS) and accounting standards. Her expertise includes managing accounting and financial control functions and establishing financial strategies for the long-term profitable growth of organizations. Prior to joining the MediPharm Labs team, Olga was a Financial Planning and Analysis Leader for multinational technology conglomerate Cisco and a Commercial Finance Manager for GE Healthcare. With global experience spanning Canada, Western Asia and Southeastern Europe, Olga is well-versed in IFRS rules and regulations to develop, plan and execute financial plans and budgets. She possesses a Master of Business Administration degree from Koç University in Istanbul.